Wellington Management Group LLP Has $405,000 Position in DaVita Inc. (NYSE:DVA)

Wellington Administration Group LLP raised its stake in shares of DaVita Inc. (NYSE:DVA – Free Report) by 9.1% throughout the 4th quarter, in line with the corporate in its most up-to-date Kind 13F submitting with the Securities & Change Fee. The fund owned 2,711 shares of the corporate’s inventory after buying an extra 227 shares throughout the interval. Wellington Administration Group LLP’s holdings in DaVita have been value $405,000 as of its most up-to-date SEC submitting.

Quite a lot of different institutional buyers additionally lately modified their holdings of DVA. MML Buyers Providers LLC grew its stake in DaVita by 1.3% within the third quarter. MML Buyers Providers LLC now owns 5,300 shares of the corporate’s inventory valued at $869,000 after shopping for an extra 68 shares over the past quarter. Change Traded Ideas LLC grew its place in shares of DaVita by 8.3% within the fourth quarter. Change Traded Ideas LLC now owns 891 shares of the corporate’s inventory valued at $133,000 after buying an extra 68 shares over the past quarter. Impression Partnership Wealth LLC elevated its stake in shares of DaVita by 3.7% within the fourth quarter. Impression Partnership Wealth LLC now owns 1,941 shares of the corporate’s inventory value $290,000 after buying an extra 70 shares throughout the interval. Contravisory Funding Administration Inc. lifted its place in shares of DaVita by 1.2% throughout the 4th quarter. Contravisory Funding Administration Inc. now owns 6,082 shares of the corporate’s inventory value $910,000 after buying an extra 73 shares over the past quarter. Lastly, Nilsine Companions LLC boosted its stake in DaVita by 0.8% throughout the 4th quarter. Nilsine Companions LLC now owns 11,160 shares of the corporate’s inventory valued at $1,669,000 after buying an extra 92 shares throughout the interval. Institutional buyers personal 90.12% of the corporate’s inventory.

DaVita Buying and selling Down 3.0 %

Shares of DaVita inventory opened at $150.85 on Tuesday. The corporate has a debt-to-equity ratio of 23.18, a present ratio of 1.26 and a fast ratio of 1.21. The corporate’s fifty day transferring common worth is $151.61 and its two-hundred day transferring common worth is $156.51. DaVita Inc. has a 52-week low of $125.64 and a 52-week excessive of $179.60. The agency has a market capitalization of $12.07 billion, a PE ratio of 14.05, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04.

DaVita (NYSE:DVA – Get Free Report) final issued its earnings outcomes on Thursday, February thirteenth. The corporate reported $2.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on fairness of 115.48% and a internet margin of seven.31%. On common, analysts anticipate that DaVita Inc. will publish 10.76 EPS for the present yr.

Wall Road Analysts Forecast Progress

A number of brokerages have commented on DVA. Sanford C. Bernstein set a $184.00 worth goal on DaVita in a analysis report on Friday, February twenty first. StockNews.com raised shares of DaVita from a “maintain” ranking to a “purchase” ranking in a analysis report on Thursday, April tenth. Barclays elevated their worth goal on shares of DaVita from $164.00 to $169.00 and gave the corporate an “equal weight” ranking in a report on Tuesday, February 18th. Lastly, Cowen restated a “maintain” ranking on shares of DaVita in a report on Tuesday, February 18th. One equities analysis analyst has rated the inventory with a promote ranking, 4 have issued a maintain ranking and two have issued a purchase ranking to the corporate. In line with MarketBeat.com, the inventory presently has a mean ranking of “Maintain” and a mean goal worth of $166.33.

View Our Newest Report on DaVita

DaVita Firm Profile

(Free Report)

DaVita Inc supplies kidney dialysis providers for sufferers affected by power kidney failure in the USA. The corporate operates kidney dialysis facilities and supplies associated lab providers in outpatient dialysis facilities. It additionally provides outpatient, hospital inpatient, and home-based hemodialysis providers; operates medical laboratories that present routine laboratory assessments for dialysis and different physician-prescribed laboratory assessments for ESRD sufferers; and administration and administrative providers to outpatient dialysis facilities.

Featured Articles

Obtain Information & Rankings for DaVita Every day – Enter your e mail deal with under to obtain a concise each day abstract of the newest information and analysts’ rankings for DaVita and associated corporations with MarketBeat.com’s FREE each day e mail e-newsletter.